Article info
PDFReview
PCSK9 inhibition and atherosclerotic cardiovascular disease prevention: does reality match the hype?
- Correspondence to Professor Kausik K Ray, Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College, Reynolds Bldg, St. Dunstan’s Rd, London W6 8RP, UK; k.ray{at}imperial.ac.uk
Citation
PCSK9 inhibition and atherosclerotic cardiovascular disease prevention: does reality match the hype?
Publication history
- Received February 8, 2017
- Revised May 1, 2017
- Accepted May 2, 2017
- First published June 8, 2017.
Online issue publication
January 18, 2021
Article Versions
- Previous version (18 January 2021).
- Previous version (18 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.